Advertisement

Sun Pharma recalls 13K bottles of chewable Cetirizine in US

The US arm of domestic drug major Sun Pharma is recalling over 13,000 bottles of antihistamine, Children's Cetirizine Hydrochloride chewable tablets, from the American market for failed specifications.

Latest News
Sun Pharma recalls 13K bottles of chewable Cetirizine in US
Add DNA as a Preferred Source

The US arm of domestic drug major Sun Pharma is recalling over 13,000 bottles of antihistamine, Children's Cetirizine Hydrochloride chewable tablets, from the American market for failed specifications.

Sun Pharmaceutical Industries Inc is recalling 13,200 bottles of the tablets in the strength of 5 mg made at Halol plant, USFDA said in its latest Enforcement Report.

The ongoing class III recall is nationwide in the USA and Puerto Rico, report added.

The reason for the recall is "failed tablet/capsule specifications: out of specification results for increased tablet hardness", United States Food and Drug Administration (USFDA) said.

As per the US health regulator, a class III recall is initiated in a situation, "in which use of or exposure to a violative product is not likely to cause adverse health consequences".

 

(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)

Find your daily dose of All Latest News including Sports NewsEntertainment NewsLifestyle News, explainers & more. Stay updated, Stay informed- Follow DNA on WhatsApp.
Read More
Advertisement
Advertisement
Advertisement